Clinical Trial Update: PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating PET imaging characteristics of C11-acetate in patients with recurrent prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• C11-acetate (C11-acetate)

Snippet

Sponsor: Phoenix Molecular Imaging | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED